GSK046

GSK046 : BD2 selective inhibitor of BRD2, BRD3, BRD4, BRDT

Structure

Information

  • BRD2
  • BRD3
  • BRD4
  • BRDT
  • Inhibitor
  • up to 10 uM

In Vitro Validations

Uniprot ID: P25440
Target Class: Epigenetic
Target SubClass: Bromodomain
Potency: IC50
Potency Value: 264 nM
Potency Assay: TR-FRET assay (BRD2 BD2)
PDB ID for probe-target interaction (3D structure): --
Target aliases:
Bromodomain-containing protein 2, RING3, KIAA9001, ...

DOI Reference: 10.1021/acs.jmedchem.0c00605

Uniprot ID: P25440
Target Class: Epigenetic
Target SubClass: Bromodomain
Potency: IC50
Potency Value: 250 nM
Potency Assay: BET mutant TR-FRET assay (BRD2 BD2)
PDB ID for probe-target interaction (3D structure): --
Target aliases:
Bromodomain-containing protein 2, RING3, KIAA9001, ...

DOI Reference: 10.1021/acs.jmedchem.0c00605

Uniprot ID: P25440
Target Class: Epigenetic
Target SubClass: Bromodomain
Potency: Kd
Potency Value: 35 nM
Potency Assay: BRD2 BD2 Bromoscan (DiscoverX)
PDB ID for probe-target interaction (3D structure): --
Target aliases:
Bromodomain-containing protein 2, RING3, KIAA9001, ...

DOI Reference: 10.1021/acs.jmedchem.0c00605

In Cell Validations

In Vivo Data

Off-Target Selectivity Assesments

Probe Selectivity in Vitro:
Selectivity within target family - BROMOScan (DiscoverX) (40 tested): clean. Selectivity outside target family - Selectivity screen (48 targets tested): clean. Clean GPCR scan exept for one off-target: HTR1D Ki = 3438.75 nM.
I have extra information to add

SERP ratings and comments


SERP Ratings

In Cell Rating
In Model Organisms

SERP Comments:

GSK046 represents a valuable probe for the target family, with clean inhibition profile across a range of related and unrelated protein families. GSK046 is also suitable for in vivo studies, however given the constrained off-target testing, it should be used with a modicum of caution, however initial findings supports it use. The molecule is metabolically stable, with no obvious toxic profile. Overall, I am happy to recommend its use.

(last updated: 15 Feb 2022 )